Author pages are created from data sourced from our academic publisher partnerships and public sources.
Bone marrow microenvironment confers imatinib resistance to chronic myelogenous leukemia and oroxylin A reverses the resistance by suppressing Stat3 pathway
Imatinib (IM) is highly effective in treatment of chronic myeloid leukemia (CML) but does not eliminate minimal residual disease (MRD), which remains a potential source of relapse. IM treatment… Expand
THE EXPRESS OF HIGH ENDOTHELIAL VENULES IN THE ENDOMETRIUM
567 Mechanisms by which combined inhibition of BET and HDAC inhibits proliferation and induces apoptosis in CTCL
Sufficient for the Development of NK T Cells Expression of CD1d2 on Thymocytes Is Not
Molecular basis for abrogation of activation of pro-inflammatory cytokines